Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy
BACKGROUND: Although genetic variants in MYH7 are the most frequent cause of pediatric genetic dilated cardiomyopathy (DCM), there are no studies available describing this entity. We sought to describe clinical features, analyze variant location, and explore predictors of bad prognosis in pediatric...
| Autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Universidad Francisco de Vitoria |
| Repositorio: | DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria |
| Idioma: | inglés |
| OAI Identifier: | oai:ddfv.ufv.es:10641/7309 |
| Acceso en línea: | https://hdl.handle.net/10641/7309 |
| Access Level: | acceso abierto |
| Palabra clave: | MYH7 dilated cardiomyopathy genetics pediatric Cardiology and Cardiovascular Medicine Journal Article Multicenter Study Yes yes |
| id |
ES_633bdc3a4cd4c34f754d1a20bfee96e8 |
|---|---|
| oai_identifier_str |
oai:ddfv.ufv.es:10641/7309 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathyde Frutos, FernandoOchoa, Juan PabloWebster, GregoryJansen, MarkRemior, PalomaRasmussen, Torsten B.Sabater-Molina, MariaBarriales-Villa, RobertoGirolami, FrancescaCesar, SergiFuentes-Cañamero, M. EugeniaGarcía-Rovés, Reyes AlvarezWahbi, KarimLimeres, JavierKubanek, MilosSlieker, Martijn G.Sarquella-Brugada, GeorgiaAbrams, Dominic J.Dooijes, DennisDomínguez, FernandoGarcia-Pavia, PabloMYH7dilated cardiomyopathygeneticspediatricCardiology and Cardiovascular MedicineJournal ArticleMulticenter StudyYesyesBACKGROUND: Although genetic variants in MYH7 are the most frequent cause of pediatric genetic dilated cardiomyopathy (DCM), there are no studies available describing this entity. We sought to describe clinical features, analyze variant location, and explore predictors of bad prognosis in pediatric MYH7-related DCM. METHODS AND RESULTS: We evaluated clinical records from 44 patients (24 men; median age at diagnosis, 0.54 [interquartile range, 0.01–10.8] years) with pathogenic/likely pathogenic variants in MYH7 diagnosed with DCM at pediatric age (<18 years) followed at 13 international centers. We also explored risk factors associated with a composite end point of end-stage heart failure defined as heart transplantation or heart failure–related death. Twenty-two patients (50%) were diagnosed at age <6 months, including 7 (16%) at birth. Left ventricular (LV) hypertrabeculation features were present in 15 (38%), particularly among patients with genetic variants in the head domain. After a median follow-up of 6.1 years (interquartile range, 1.9–13.4), 15 patients (36%) required a heart transplant (n=14) or died due to end-stage heart failure (n=1), 15 patients (36%) persisted with systolic dysfunction despite treatment, 12 (29%) had a significant increase in LV ejection fraction, and 2 were lost to follow-up. Overall, end-stage heart failure event rate was 25% at 5 years. New York Heart Association class III to IV (hazard ratio [HR], 7.67 [95% CI, 2.16–27.2]; P=0.002) and LV ejection fraction ≤35% (HR, 4.00 [95% CI, 1.11–14.4]; P=0.03) were the best predictors of bad prognosis. CONCLUSIONS: Pediatric MYH7-related DCM is characterized by early onset, frequent LV hypertrabeculation, and poor prognosis. Advanced New York Heart Association class and low LV ejection fraction emerged as predictors of end-stage heart failure.Facultad de Medicina20242024-01-0120242024-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10641/7309reponame:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoriainstname:Universidad Francisco de VitoriaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:ddfv.ufv.es:10641/73092026-06-11T12:44:57Z |
| dc.title.none.fl_str_mv |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy |
| title |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy |
| spellingShingle |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy de Frutos, Fernando MYH7 dilated cardiomyopathy genetics pediatric Cardiology and Cardiovascular Medicine Journal Article Multicenter Study Yes yes |
| title_short |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy |
| title_full |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy |
| title_fullStr |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy |
| title_full_unstemmed |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy |
| title_sort |
Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy |
| dc.creator.none.fl_str_mv |
de Frutos, Fernando Ochoa, Juan Pablo Webster, Gregory Jansen, Mark Remior, Paloma Rasmussen, Torsten B. Sabater-Molina, Maria Barriales-Villa, Roberto Girolami, Francesca Cesar, Sergi Fuentes-Cañamero, M. Eugenia García-Rovés, Reyes Alvarez Wahbi, Karim Limeres, Javier Kubanek, Milos Slieker, Martijn G. Sarquella-Brugada, Georgia Abrams, Dominic J. Dooijes, Dennis Domínguez, Fernando Garcia-Pavia, Pablo |
| author |
de Frutos, Fernando |
| author_facet |
de Frutos, Fernando Ochoa, Juan Pablo Webster, Gregory Jansen, Mark Remior, Paloma Rasmussen, Torsten B. Sabater-Molina, Maria Barriales-Villa, Roberto Girolami, Francesca Cesar, Sergi Fuentes-Cañamero, M. Eugenia García-Rovés, Reyes Alvarez Wahbi, Karim Limeres, Javier Kubanek, Milos Slieker, Martijn G. Sarquella-Brugada, Georgia Abrams, Dominic J. Dooijes, Dennis Domínguez, Fernando Garcia-Pavia, Pablo |
| author_role |
author |
| author2 |
Ochoa, Juan Pablo Webster, Gregory Jansen, Mark Remior, Paloma Rasmussen, Torsten B. Sabater-Molina, Maria Barriales-Villa, Roberto Girolami, Francesca Cesar, Sergi Fuentes-Cañamero, M. Eugenia García-Rovés, Reyes Alvarez Wahbi, Karim Limeres, Javier Kubanek, Milos Slieker, Martijn G. Sarquella-Brugada, Georgia Abrams, Dominic J. Dooijes, Dennis Domínguez, Fernando Garcia-Pavia, Pablo |
| author2_role |
author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Facultad de Medicina |
| dc.subject.none.fl_str_mv |
MYH7 dilated cardiomyopathy genetics pediatric Cardiology and Cardiovascular Medicine Journal Article Multicenter Study Yes yes |
| topic |
MYH7 dilated cardiomyopathy genetics pediatric Cardiology and Cardiovascular Medicine Journal Article Multicenter Study Yes yes |
| description |
BACKGROUND: Although genetic variants in MYH7 are the most frequent cause of pediatric genetic dilated cardiomyopathy (DCM), there are no studies available describing this entity. We sought to describe clinical features, analyze variant location, and explore predictors of bad prognosis in pediatric MYH7-related DCM. METHODS AND RESULTS: We evaluated clinical records from 44 patients (24 men; median age at diagnosis, 0.54 [interquartile range, 0.01–10.8] years) with pathogenic/likely pathogenic variants in MYH7 diagnosed with DCM at pediatric age (<18 years) followed at 13 international centers. We also explored risk factors associated with a composite end point of end-stage heart failure defined as heart transplantation or heart failure–related death. Twenty-two patients (50%) were diagnosed at age <6 months, including 7 (16%) at birth. Left ventricular (LV) hypertrabeculation features were present in 15 (38%), particularly among patients with genetic variants in the head domain. After a median follow-up of 6.1 years (interquartile range, 1.9–13.4), 15 patients (36%) required a heart transplant (n=14) or died due to end-stage heart failure (n=1), 15 patients (36%) persisted with systolic dysfunction despite treatment, 12 (29%) had a significant increase in LV ejection fraction, and 2 were lost to follow-up. Overall, end-stage heart failure event rate was 25% at 5 years. New York Heart Association class III to IV (hazard ratio [HR], 7.67 [95% CI, 2.16–27.2]; P=0.002) and LV ejection fraction ≤35% (HR, 4.00 [95% CI, 1.11–14.4]; P=0.03) were the best predictors of bad prognosis. CONCLUSIONS: Pediatric MYH7-related DCM is characterized by early onset, frequent LV hypertrabeculation, and poor prognosis. Advanced New York Heart Association class and low LV ejection fraction emerged as predictors of end-stage heart failure. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2024-01-01 2024 2024-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/10641/7309 |
| url |
https://hdl.handle.net/10641/7309 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria instname:Universidad Francisco de Vitoria |
| instname_str |
Universidad Francisco de Vitoria |
| reponame_str |
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria |
| collection |
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869409556983971840 |
| score |
15,812429 |